Literature DB >> 25931197

Diagnosis and Treatment of Typhoid Fever and Associated Prevailing Drug Resistance in Northern Ethiopia.

Araya Gebreyesus Wasihun1, Letemichael Negash Wlekidan2, Senay Aregawi Gebremariam3, Abadi Luel Welderufael4, Saravanan Muthupandian2, Tadesse Dejenie Haile5, Tsehaye Asmelash Dejene2.   

Abstract

OBJECTIVE: To determine diagnostic value of the Widal test, treatment pattern of febrile patients and antimicrobial drug susceptibility pattern of blood isolates.
METHODS: Using cross sectional methods, blood samples were collected for culture and Widal test from 502 febrile outpatients attending Mekelle hospital and Mekelle health center with similar symptoms to typhoid. Sensitivity, specificity for anti-TH and anti-TO titers using culture confirmed typhoid fever cases, and Kappa agreement between Titer and slide Widal tests were calculated. Treatment pattern of patients and antimicrobial susceptibility pattern of the blood isolates was assessed.
RESULTS: From the 502 febrile patients, 8(1.6%) of them had culture-proven typhoid fever. However, patients who have results indicative of recent infection by O and H antigens of the Widal slide agglutination test were 343 (68.5%), with specificity and sensitivity of 33% and 100%, respectively. Over prescription of antibiotics was seen by Widal slide test for Ciprofloxacin 268 (76.1%), Amoxicillin- Clavulanic acid 9(2.6%), Amoxicillin 8(2.4%) and Chloranphenicol 8(2.4%). Tube titer positivity was seen in 23(5.3%) patients with 75% sensitivity and 95.8% specificity. Widal slide and Tube titer tests showed poor agreement for both antigens (kappa=0.02 for O) and (Kappa=0.09 for H). A single anti-TH titer of ≥ 1:160 and anti-TO titer ≥ 1:80 higher in our study showed an indication for typhoid fever infection. Drug resistance pattern of blood isolates ranges from 0-89.7% for gram positive and 0-100% for Gram negative, with an overall multi-drug resistance rate of 61.7%.
CONCLUSION: Patients were wrongly diagnosed and treated for typhoid fever by Widal test. The tube titration method was relatively good but still had poor sensitivity. Blood isolates showed multi drug resistance, which may be due to the indiscriminate prescription as seen in this study. Based on our results, the slide Widal test is not helpful in the diagnosis of typhoid, hence other tests with rapid, feasible, better sensitivity and specificity are urgently needed in Ethiopia.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Diagnosis; Febrile-patients; Resistance; Sensitivity; Specificity; Treatment; Typhoid; Widal test

Mesh:

Substances:

Year:  2015        PMID: 25931197     DOI: 10.1016/j.ijid.2015.04.014

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  16 in total

1.  Clinical Profile and the Role of Rapid Serological Tests: Typhifast IgM and Enterocheck WB in the Diagnosis of Typhoid Fever.

Authors:  Rahul J Bhume; Prakash Babaliche
Journal:  Indian J Crit Care Med       Date:  2020-05

2.  Antimicrobial Resistance of Sterile Site Infections in Sub-Saharan Africa: A Systematic Review.

Authors:  Meklit Workneh; Morgan J Katz; Mohammed Lamorde; Sara E Cosgrove; Yukari C Manabe
Journal:  Open Forum Infect Dis       Date:  2017-10-06       Impact factor: 3.835

3.  Diagnostic accuracy of antigen-based immunochromatographic rapid diagnostic tests for the detection of Salmonella in blood culture broth.

Authors:  Laura M F Kuijpers; Panha Chung; Marjan Peeters; Marie-France Phoba; Chun Kham; Barbara Barbé; Octavie Lunguya; Jan Jacobs
Journal:  PLoS One       Date:  2018-03-08       Impact factor: 3.240

4.  Typhoid fever: clinical presentation and associated factors in febrile patients visiting Shashemene Referral Hospital, southern Ethiopia.

Authors:  Limenih Habte; Endale Tadesse; Getachew Ferede; Anteneh Amsalu
Journal:  BMC Res Notes       Date:  2018-08-22

5.  Resistance profile of clinically relevant bacterial isolates against fluoroquinolone in Ethiopia: a systematic review and meta-analysis.

Authors:  Mekonnen Sisay; Fitsum Weldegebreal; Tewodros Tesfa; Zerihun Ataro; Dadi Marami; Habtamu Mitiku; Birhanu Motbaynor; Zelalem Teklemariam
Journal:  BMC Pharmacol Toxicol       Date:  2018-12-12       Impact factor: 2.483

6.  Plasma Immunoglobulin A Responses Against 2 Salmonella Typhi Antigens Identify Patients With Typhoid Fever.

Authors:  Jason R Andrews; Farhana Khanam; Nazia Rahman; Motaher Hossain; Isaac I Bogoch; Krista Vaidya; Meagan Kelly; Stephen B Calderwood; Taufiqur Rahman Bhuiyan; Edward T Ryan; Firdausi Qadri; Richelle C Charles
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

7.  Ascertaining the burden of invasive Salmonella disease in hospitalised febrile children aged under four years in Blantyre, Malawi.

Authors:  Chisomo L Msefula; Franziska Olgemoeller; Ndaru Jambo; Dalitso Segula; Trinh Van Tan; Tonney S Nyirenda; Wilfred Nedi; Neil Kennedy; Matthew Graham; Marc Y R Henrion; Stephen Baker; Nicholas Feasey; Melita Gordon; Robert S Heyderman
Journal:  PLoS Negl Trop Dis       Date:  2019-07-17

8.  Antimicrobial resistance in Africa: a systematic review.

Authors:  Birkneh Tilahun Tadesse; Elizabeth A Ashley; Stefano Ongarello; Joshua Havumaki; Miranga Wijegoonewardena; Iveth J González; Sabine Dittrich
Journal:  BMC Infect Dis       Date:  2017-09-11       Impact factor: 3.667

9.  Diagnosis and Treatment of Human Salmonellosis in Addis Ababa City, Ethiopia.

Authors:  Legesse Garedew; Semaria Solomon; Yoseph Worku; Hilina Worku; Debela Gemeda; Gada Lelissa; Yeshwondm Mamuye; Rajiha Abubeker; Amete Mihret; Surafel Fentaw; Abeibe Worku; Melish Bahiru; Girume Erenso
Journal:  Biomed Res Int       Date:  2018-05-23       Impact factor: 3.411

10.  Community-based prevalence of typhoid fever, typhus, brucellosis and malaria among symptomatic individuals in Afar Region, Ethiopia.

Authors:  Biruk Zerfu; Girmay Medhin; Gezahegne Mamo; Gezahegn Getahun; Rea Tschopp; Mengistu Legesse
Journal:  PLoS Negl Trop Dis       Date:  2018-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.